- Condition: Hepatitis C, Chronic
Interventions: Drug: ALS-002158; Drug: Placebo
Sponsors: Alios Biopharma Inc.; Alios Biopharma Inc.; Vertex Pharmaceuticals Incorporated
Recruiting - verified March 2012 - Conditions: Respiratory Tract Infection; Vitamin D Deficiency
Interventions: Dietary Supplement: Cholecalciferol; Dietary Supplement: Placebo
Sponsors: Menzies Research Institute Tasmania; Menzies Research Institute Tasmania; Royal Hobart Hospital Research Foundation (funding source)
Recruiting - verified April 2012 - Condition: Healthy Volunteers
Intervention: Drug: REGN1154 or placebo
Sponsors: Regeneron Pharmaceuticals; Regeneron Pharmaceuticals
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: SERETIDE Rotacaps; Drug: SERETIDE Diskus
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride (0.5mg, fasted state); Drug: Dutasteride (0.5mg, fed state); Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state); Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state); Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state); Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state); Drug: Harnal-D Tablets with water (fasted state); Drug: Harnal-D Tablets with water (fed state); Drug: Harnal-D tablets without water (fasted state)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified December 2011 - Condition: Healthy
Interventions: Drug: BG00012 Dose 1; Drug: BG00012 Dose 2
Sponsors: Biogen Idec; Biogen Idec
Recruiting - verified March 2012 - Condition: Hepatitis C, Chronic
Interventions: Drug: PPI-668; Drug: Placebo
Sponsors: Presidio Pharmaceuticals, Inc.; Presidio Pharmaceuticals, Inc.
Recruiting - verified March 2012 - Condition: Brain Injuries, Traumatic
Interventions: Drug: NNZ-2566; Drug: Placebo
Sponsors: Neuren Pharmaceuticals Limited; Neuren Pharmaceuticals Limited
Recruiting - verified March 2012 - Condition: Healthy Volunteers
Interventions: Drug: OZ439; Drug: OZ439 mesylate; Drug: OZ439 mesylate; Drug: OZ439
Sponsors: Medicines for Malaria Venture; Medicines for Malaria Venture; Nucleus Network Ltd; INC Research
Recruiting - verified April 2012 - Condition: Pain
Intervention:
Sponsors: IX Biopharma Pte. Ltd.; IX Biopharma Pte. Ltd.
Recruiting - verified June 2011 - Conditions: Ulcerative Colitis; Crohn's Disease
Interventions: Drug: AMG 181; Other: Placebo for AMG 181
Sponsors: Amgen; Amgen
Recruiting - verified April 2012 - Condition: Crohn's Disease
Intervention: Drug: AMG 139
Sponsors: Amgen; Amgen
Recruiting - verified January 2012 - Condition: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Intervention: Biological: GSK580299 (CervarixTM)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Ulcerative Colitis
Intervention: Drug: Amg 181
Sponsors: Amgen; Amgen
Recruiting - verified April 2012
 |
Find Clinical Trials for Healthy Volunteers in Australia |
Clinical Trial Locations 